Accessibility Menu
HeartSciences logo

HeartSciences

(NASDAQ) HSCS

Current Price$2.61
Market Cap$8.18M
Since IPO (2022)-98%
5 YearN/A
1 Year-15%
1 Month-13%

HeartSciences Financials at a Glance

Market Cap

$8.18M

Revenue (TTM)

$8.67K

Net Income (TTM)

$1.99B

EPS (TTM)

$-4.93

P/E Ratio

-0.52

Dividend

$0.00

Beta (Volatility)

0.71 (Low)

Price

$2.61

Volume

542

Open

$2.57

Previous Close

$2.57

Daily Range

$2.57 - $2.61

52-Week Range

$2.01 - $6.47

HSCS News

No articles available.

HSCS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About HeartSciences

Industry

Healthcare Equipment and Supplies

Employees

15

CEO

Andrew Christopher Simpson

Headquarters

Southlake, TX 76092-1552, US

HSCS Financials

Key Financial Metrics (TTM)

Gross Margin

-11%

Operating Margin

-899%

Net Income Margin

-229751%

Return on Equity

-382%

Return on Capital

-0%

Return on Assets

-26%

Earnings Yield

-1.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.18M

Shares Outstanding

3.18M

Volume

542

Short Interest

0.00%

Avg. Volume

28.75K

Financials (TTM)

Gross Profit

$125.48K

Operating Income

$8.35M

EBITDA

$8.14M

Operating Cash Flow

$7.41M

Capital Expenditure

$30.19K

Free Cash Flow

$7.44M

Cash & ST Invst.

$1.10M

Total Debt

$2.99M

HeartSciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$33.24K

N/A

Gross Margin

0.00%

N/A

Market Cap

$8.18M

N/A

Market Cap/Employee

$545.65K

N/A

Employees

15

N/A

Net Income

$1.99B

-78172.1%

EBITDA

$1.90M

+18.6%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Net Cash

$470.10M

-120265.5%

Accounts Receivable

$0.00

N/A

Inventory

$657.28M

+100687.9%

Long Term Debt

$633.69M

+183130.9%

Short Term Debt

$3.23B

+122329.5%

Return on Assets

-26.36%

N/A

Return on Invested Capital

-0.10%

N/A

Free Cash Flow

$3.40B

-208024.1%

Operating Cash Flow

$3.41B

-210626.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BCLIBrainstorm Cell Therapeutics Inc.
$0.90+1.99%
BMRABiomerica, Inc.
$2.00-3.85%
IBOImpact BioMedical Inc.
$0.44-5.83%
PAVMPAVmed Inc.
$9.65-0.41%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.89-0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.43-0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.62+0.04%
QQQInvesco QQQ Trust
$585.01-0.01%

Questions About HSCS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.